Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 21, 2007Blood

How I treat indolent lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

John G. GribbenJohn G. GribbenBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

John G. Gribben (2007) studied this question.

synapsesocial.com/papers/6a86e414bb0787ff27ca0ec7https://doi.org/10.1182/blood-2006-10-041863
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia2000 · 1,009 citations
  2. 2Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma1991 · 687 citations
  3. 3A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma1997 · 2,481 citations
  4. 4Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy2004 · 235 citations
  5. 5Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S99112006 · 280 citations